News
Dog Club on MSN5h
Dogs May Soon Live Longer Thanks to Breakthrough DrugEver wish that you could make your dog's life longer? While crossing the rainbow bridge is part of a dog's short life, ...
Everyday Health on MSN5h
Taking Too Many Supplements? Here's How to Tell, and Why It Can Be RiskySupplements, when approved by your doctor, may help you meet your nutritional needs. But there are potential health risks to ...
LIKMEZ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing Five U.S. government proposals submitted, totalling up to US$125 million HALIFAX, Nova Scotia ...
Viking Therapeutics initiates VANQUISH phase 3 obesity clinical programme with GLP-1/GIP agonist VK2735: San Diego Thursday, June 26, 2025, 10:00 Hrs [IST] Viking Therapeutics, In ...
Detailed Phase IIIb STEP UP trial results presented at the 2025 ADA Scientific Sessions found that an investigational 7.2 mg dose of Wegovy (semaglutide) led to a mean weight loss of 21% in adults ...
Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...
The Food and Drug Administration (FDA) has approved Harliku ™ (nitisinone) for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria.
Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback